FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved Viatris Specialty LLC's supplemental application for REVATIO (sildenafil citrate), enabling changes to the drug's approved labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)